Where is Rayca located?

Rayca is headquartered in London, United Kingdom.

Who is the current CEO of Rayca?

Pouya Behrouzi of Rayca. They have also founded 1 company.

How many employees does Rayca have?

As of Jul 01, 2024, the latest employee count at Rayca is 10.

Is Rayca a funded company?

Rayca is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Rayca rank among its competitors?

Rayca ranks 22nd amongst 41 active competitors, of which 16 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Tempus, which secured $460M in Jul, 2026.

Who are the top competitors of Rayca?

Rayca's top competitors include Tempus, Artera and 4baseCare. Among them, Tempus secured the most recent funding round in July, 2026.

Rayca - 2026 Company Profile, Team & Competitors

Company Details

AI-powered platform for precision oncology and clinical research. The company offers OncoCrest which employs artificial intelligence (AI) and gene expression profiling to enable predictive modeling of drug responses in the realm of cancer therapeutic and RSA2 an analytical platform for the clinical research industry.

Website: raycabio.com
Social
Email ID: *****@raycabio.com
Phone Number: +44 **********

Key Metrics

Founded Year

2021

Location

London, United Kingdom

Stage

Unfunded

Ranked

22^nd among 41 active competitors

Employee Count

10 as on Jul 01, 2024

Similar Companies

Tempus & 46 more

View Rayca's full profile

Rayca has not raised any funding rounds yet.

The founders of Rayca are Mahdi Muhaddesi and Pouya Behrouzi. Pouya Behrouzi is the CEO of Rayca.

Here are the details of Rayca's key team members:

Mahdi Muhaddesi: Co-Founder of Rayca.
Contact Info: 1 email address
Pouya Behrouzi: Co-Founder & CEO of Rayca.
Contact Info: 1 email address

View details of Rayca's Founder profiles and Board Members

Rayca's employee count trend

Rayca has 10 employees as of Jul 24. Here is Rayca's employee count trend over the years:

Uncover Rayca's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Rayca include Tempus, Artera and 4baseCare. Here is the list of Top 10 competitors of Rayca, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	T. Rowe Price, New Enterprise Associates ... & 11 others	77/100
2nd	Artera 2021, Menlo Park (United States), Series A	AI-derived prognostic biomarker test for cancer detection	$135M	Walden Catalyst, Breyer Capital & 23 others	68/100
3rd	4baseCare 2018, Bengaluru (India), Series B	Provider of precision oncology solutions, including genomic testing and digital health	$25.9M	Tremis Consultancy, Yali Capital & 41 others	67/100
4th	CancerIQ 2013, Chicago (United States), Series B	Cloud-based platform to doctors, for identifying cancer risk patients and delivering care plans	$24.8M	Merck Global Health Innovation Fund, Amgen ... & 11 others	62/100
5th	Personalis 2011, Menlo Park (United States), Public	Provider of genomic sequencing and diagnosis software for the healthcare industry	$87.3M	Abingworth, Lightspeed Venture Partners & 5 others	61/100
6th	Imagene 2020, Tel Aviv (Israel), Series B	Provider of an AI-based cancer diagnosis and precision medicine planning software for healthcare providers	$45M	Blumberg Capital, Europa & 4 others	56/100
7th	Genomate Health 2022, Cambridge (United States), Series A	AI-based computational system cancer treatment decisions	$10.4M	STRT, Plug and Play Tech Center	52/100
8th	Perthera 2012, Mclean (United States), Series A	Personalized molecular cancer profiling through genomics and proteomics	$17.8M	Pilot Growth Equity, Invictus Growth	47/100
9th	LinkDoc 2014, Haidian (China), Series D	Provider of the oncology-focused database	$263M	China Investment Corporation, CBC Capital ... & 10 others	46/100
10th	QUANTRO Therapeutics 2020, Vienna (Austria), Seed	Developer of transcriptional fingerprinting therapeutic solutions for drug discovery	-	Boehringer Ingelheim Venture Fund, Evotec	44/100
22nd	Rayca 2021, London (United Kingdom), Unfunded	AI-powered platform for precision oncology and clinical research	-	-	27/100